Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mylan Labs
Mylan Labs
Mylan scores review of Allergan's Restasis IP, but analysts aren't worried about the med's fate
Fierce Pharma
Sun, 12/11/16 - 11:44 am
Mylan Labs
Allergan
Restasis
patents
generics
After EpiPen controversy, watchdog to review Medicaid rebates
Stat/Pharmalot
Sat, 12/10/16 - 10:28 am
Medicaid
Medicaid Drug Rebate Program
Mylan Labs
EpiPens
Mylan eyes up to 3,500 layoffs in post-M&A cost-cutting drive
Fierce Pharma
Wed, 12/7/16 - 10:57 am
Mylan Labs
layoffs
M&A
Meda
Abbott Labs
Is Mylan Being Really Smart -- Or Really Arrogant?
Motley Fool
Sun, 12/4/16 - 12:26 pm
Mylan Labs
EpiPens
Sentate
Charles Grassley
Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
Medical Marketing and Media
Fri, 12/2/16 - 11:27 am
Mylan Labs
EpiPens
drug pricing
Heather Bresch
Pharma CEOs
Grassley upset Mylan CEO to talk at industry event but won’t testify before Congress
Stat/Pharmalot
Tue, 11/29/16 - 05:38 pm
Mylan Labs
Charles Grassley
Heather Bresch
US Congress
Mylan refuses to testify at Senate hearing about EpiPen rebates to Medicaid
Stat/Pharmalot
Tue, 11/22/16 - 12:19 pm
Mylan Labs
EpiPen
rebates
FTC is ‘aware’ of concerns over possible Mylan antitrust violations
Stat/Pharmalot
Mon, 11/21/16 - 11:37 am
FTC
Mylan Labs
antitrust
Senators demand Mylan repay $50 million to the Pentagon for EpiPen
Stat/Pharmalot
Tue, 11/8/16 - 04:26 pm
Mylan Labs
EpiPen
drug pricing
Department of Defense
Mylan's Troubles Just Won't Stop Showing Up
TheStreet.com
Sat, 11/5/16 - 02:03 pm
Mylan Labs
generics
price collusion
drug pricing
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
Bloomberg
Fri, 11/4/16 - 09:42 am
collusion
DOJ
generics
Sanofi
Eli Lilly
Merck
Novo Nordisk
Mylan Labs
drug pricing
Timeline of a crisis: How Mylan responded to the EpiPen controversy
Medical Marketing and Media
Tue, 11/1/16 - 10:06 am
Mylan Labs
EpiPen
Heather Bresch
drug pricing
NCPA: FDA to blame for EpiPen price hikes
BioPharma Dive
Wed, 10/26/16 - 09:24 pm
NCPA
FDA
EpiPens
drug pricing
Mylan Labs
EpiPen rival Auvi-Q will return to market next year
Thu, 10/27/16 - 04:04 pm
EpiPen Competitor Auvi-Q To Return To Market, Promising Lower Costs For Patients
Forbes
Wed, 10/26/16 - 09:30 am
EpiPens
Auvi-Q
Kaleo
Mylan Labs
EpiPen prescriptions continue to climb, but market share dropped
Stat/Pharmalot
Tue, 10/25/16 - 04:00 pm
EpiPen
Mylan Labs
EpiPen Shows A Path To Solve The Bigger Drug Pricing Challenge
Forbes
Mon, 10/24/16 - 09:33 am
EpiPen
drug pricing
Mylan Labs
Mylan Now Likely An Acquisition Target With 100% Upside Possible
Seeking Alpha
Mon, 10/17/16 - 11:29 am
Mylan Labs
M&A
DOJ
Mylan's next problem? A shareholder suit demanding damages
Fierce Pharma
Fri, 10/14/16 - 11:58 am
Mylan Labs
EpiPens
Class Action Lawsuit
shareholders
Mylan Surges After Quickly Settling With DoJ Over EpiPen Medicaid Rebates
Forbes
Sat, 10/8/16 - 03:54 pm
Mylan Labs
EpiPens
DOJ
Medicaid
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »